This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| LUCAS (medical device) | |
|---|---|
| Name | LUCAS mechanical chest compression system |
| Classification | Cardiopulmonary resuscitation device |
| Inventor | Axel H. Källstrand |
| Manufacturer | Stryker Corporation |
| Introduced | 2000s |
| Synonyms | Mechanical CPR device |
LUCAS (medical device) is a piston-driven, battery-powered mechanical cardiopulmonary resuscitation device designed to deliver consistent chest compressions during cardiac arrest. It is used by emergency medical services, hospital teams, and military medical units to maintain perfusion during cardiopulmonary resuscitation and during transport for interventions such as percutaneous coronary intervention and emergency thoracotomy. The device integrates into advanced life support workflows employed by organizations like American Heart Association, European Resuscitation Council, Resuscitation Council (United Kingdom), and national ambulance services.
The device provides automated mechanical compressions using a suction-cup or pad attached to a backboard, enabling uninterrupted compressions during procedures that would otherwise interrupt manual chest compressions performed by providers from organizations including National Health Service (England), Los Angeles County Fire Department, and New York City Fire Department. It aims to deliver guideline-concordant compression depth and rate advocated by the American Heart Association and the European Resuscitation Council (ERC). The device has been deployed in prehospital emergency medical systems, community cardiac arrest programs, hospital emergency departments, and military casualty care in theaters such as Afghanistan and Iraq.
Development traces to research on mechanical chest compression in the late 20th century involving teams associated with institutions like Karolinska Institutet and companies from Sweden. Early prototypes were influenced by work at research centers including Mayo Clinic and Massachusetts General Hospital that studied automated circulatory support and mechanical circulatory devices. Commercialization involved partnerships with medical device firms and emergency medicine stakeholders including EMS World and standards bodies such as International Liaison Committee on Resuscitation. Iterations of the product were acquired or manufactured by companies including Jolife AB before later involvement by Stryker Corporation and distribution agreements with international medical suppliers in regions like Europe, North America, and Asia.
The device consists of a motorized piston assembly mounted on a proximal frame and a patient backboard to stabilize the thorax, similar in logistical role to devices evaluated at Copenhagen University Hospital and St. Thomas' Hospital. The mechanism uses a suction cup or compression pad to apply force at the sternum, calibrated to meet depth and rate parameters promoted by American Heart Association and monitored during trials conducted with partners like University of Copenhagen and Harvard Medical School. Power supplies are typically rechargeable batteries compatible with ambulance electrical systems used by agencies such as London Ambulance Service and Fire Department of New York. The device permits continuous compressions during radiographic procedures in catheterization laboratories like those in Mount Sinai Hospital and is designed for compatibility with patient transport systems used by Air Ambulance Service units.
Randomized controlled trials and observational registries evaluated device performance versus manual compressions in studies led by investigators at Karolinska Institutet, Randomized Evaluation of Mechanical versus Manual Cardiopulmonary Resuscitation investigators, and multicenter collaborations involving hospitals such as Rigshospitalet and Brigham and Women's Hospital. Outcomes assessed included return of spontaneous circulation, survival to hospital admission, and neurologically intact survival to discharge measured with scales used at Cleveland Clinic and Johns Hopkins Hospital. Meta-analyses incorporating data from New England Journal of Medicine–type publications and trial registries examined whether mechanical compressions improved outcomes; results were heterogeneous, with some studies showing noninferiority in hemodynamic measures reported by teams at University of Toronto and others showing no significant survival benefit in trials modeled after large pragmatic studies performed in Sweden and Denmark.
Indications align with cardiac arrest protocols used by European Resuscitation Council and American Heart Association algorithms: out-of-hospital cardiac arrest, in-hospital cardiac arrest where continuous compressions are necessary, and during coronary angiography or extracorporeal membrane oxygenation cannulation in centers like Cleveland Clinic and Mayo Clinic. Contraindications or cautions mirror guidance from specialty societies including Society of Critical Care Medicine and may include severe chest trauma, patient size limitations documented in device labeling from manufacturers affiliated with Food and Drug Administration and European Medicines Agency, and situations where device placement would delay defibrillation or advanced airway management as per protocols used by Royal College of Emergency Medicine and national EMS authorities.
Reported complications in case series and registries compiled by academic centers such as University of Oslo and University of Helsinki include rib fractures, sternal fractures, and rare visceral injuries documented in trauma reports from tertiary centers like King's College Hospital and St. Michael's Hospital. Device limitations include fixed compression geometry that may be less adaptable to extreme body habitus compared with manual compressions performed by experienced teams at institutions like Cleveland Clinic and potential interference with ultrasound windows used in point-of-care imaging programs at hospitals such as Guy's and St Thomas' NHS Foundation Trust. Operational constraints—battery life, maintenance, sterilization—are managed by procurement and biomedical engineering divisions in systems including Veterans Health Administration and municipal EMS fleets.
Regulatory clearance was obtained through pathways administered by agencies such as the Food and Drug Administration, European Medicines Agency, and national competent authorities in countries including Sweden, Germany, Japan, and Australia. Adoption has been driven by prehospital systems like London Ambulance Service, municipal EMS in Toronto, and hospital networks in the United States and Europe integrating device protocols into resuscitation bundles promoted by American Heart Association and European Resuscitation Council. International guidelines and registry data from entities such as Resuscitation Council (United Kingdom), Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin, and national cardiac arrest registries continue to shape practice, procurement, and training efforts.
Category:Medical devices Category:Cardiopulmonary resuscitation